Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …
SJ Hecker, KR Reddy, O Lomovskaya… - Journal of medicinal …, 2020 - ACS Publications
Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B …
Antibiotic resistance caused by β-lactamase production continues to present a growing challenge to the efficacy of β-lactams and their role as the most important class of clinically …
EA Popova, RE Trifonov… - Russian Chemical …, 2019 - iopscience.iop.org
The tetrazole ring is an important pharmacophore. It is a structural component in many drugs, drug candidates (or lead compounds) and various biochemical reagents. This review …
LC Ju, Z Cheng, W Fast, RA Bonomo… - Trends in …, 2018 - cell.com
Metallo-β-lactamases (MBLs) are a significant clinical problem because they hydrolyze and inactivate nearly all β-lactam-containing antibiotics. These 'lifesaving drugs' constitute> 50 …
New Delhi metallo-β-lactamase-1 exhibits a broad substrate profile for hydrolysis of the penicillin, cephalosporin and 'last resort'carbapenems, and thus confers bacterial resistance …
The worldwide proliferation of life-threatening metallo-β-lactamase (MBL)-producing Gram- negative bacteria is a serious concern to public health. MBLs are compromising the …
L Gavara, L Sevaille, F De Luca, P Mercuri… - European Journal of …, 2020 - Elsevier
Resistance to β-lactam antibiotics in Gram-negatives producing metallo-β-lactamases (MBLs) represents a major medical threat and there is an extremely urgent need to develop …
C Kaya, J Konstantinović, AM Kany… - Journal of Medicinal …, 2022 - ACS Publications
Drug-resistant pathogens pose a global challenge to public health as they cause diseases that are extremely difficult to cure. Metallo-β-lactamases (MBLs) are a diverse set of zinc …